Back

Should we use levosimendan?

20 March 2026 (17:12 - 17:24)
Organised by: Logo
Congress Presentation Part of: New drugs for circulatory shock: from existing practice to ongoing trials in medical management of circulatory shock Acute Cardiac Care ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Professor Alain Combes

Pitie Salpetriere APHP University Hospital, Paris (France)

4 More presentations in this session

Presentation thumbnail
Current evidence in inotropes and vasodilators for cardiogenic shock
Doctor R. Mathew (Ottawa, CA)
Slides Video
Presentation thumbnail
Vasopressors beyond noradrenalin
Professor D. Morrow (Boston, US)
Slides Video
Presentation thumbnail
Novel agents in cardiogenic shock
Ms M. Padilla Lopez (Barcelona, ES)
Slides Video
Presentation thumbnail
New drugs for circulatory shock: from existing practice to ongoing trials in first-line management of circulatory shock - discussion
Video

Access the full session

Session thumbnail
New drugs for circulatory shock: from existing practice to ongoing trials in medical management of circulatory shock

The Event

Event poster

ESC Acute CardioVascular Care 2026

20 March 2026 17:12 CET
You may be interested in
thumbnail
Congress Presentation
New drugs for circulatory shock: from existing practice to ongoing trials in first-line management of circulatory shock - discussion
thumbnail
Congress Presentation
Levosimendan in patients with cardiogenic shock refractory to dobutamine weaning
thumbnail
Congress Presentation
The experience of more than three hundred levosimendan administrations: what we have learned

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources